Life Science News
Latest updates from the biotech and pharma world
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
Moderna cancer vaccine holds up; IO Biotech considers a sale
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna gets funding for H5 pandemic influenza vaccine
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Moderna's reshaping rolls on with 3 more pipeline purges
#Moderna reshaping#vaccine Spikevax#pipeline purges#infectious diseases#mRNA programs
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
#Blue Lake#Inhibikase Therapeutics#Olema Oncology#Elevidys trial#Hansa Biopharma
Moderna secures $1.5B lifeline as it looks to break even in 2028
#Moderna secures#day event#disease programs#analyst day#invest revenue